La Jolla, CA, United States of America

Jesse Dixon

This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2019-2024.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jesse Dixon

Introduction

Jesse Dixon is an accomplished inventor based in La Jolla, CA (US). With a focus on advancements in genomic research, he has made significant contributions to the field. His work has led to the development of innovative methods for haplotype determination, which are crucial for understanding genetic variations.

Latest Patents

Jesse Dixon holds a total of 3 patents. His latest patents include groundbreaking work on whole-genome haplotype reconstruction. This invention relates to methods for haplotype determination at the whole genome level, as well as targeted haplotype determination. These advancements are vital for enhancing our understanding of genetic information and its implications in various fields, including medicine.

Career Highlights

Dixon is affiliated with the Ludwig Institute for Cancer Research Limited, where he applies his expertise in genomic research. His role at this prestigious institution allows him to collaborate with leading scientists and contribute to significant advancements in cancer research.

Collaborations

Some of his notable coworkers include Bing Ren and Siddarth Selvaraj. Their collaborative efforts have further enriched the research environment and fostered innovation in the field of genomics.

Conclusion

Jesse Dixon's contributions to the field of genomic research through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for future innovations in understanding genetic information.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…